COMMUNIQUÉS West-GlobeNewswire

IPSEN S.A - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale 2025
30/04/2025
Information réglementée Destiné uniquement aux médias internationaux et à la communauté d’investisseurs Informations concernant la tenue de l’Assemblée Générale Mixte du 21 mai 2025 d’Ipsen S.A. Modalités de mise à [...]
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024
30/04/2025
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024 NANTES, France, 30 avril 2025, 18 heures - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), une société de [...]
Best Probiotics for Bloating and Gas 2025: Top Probiotic Gut Health Supplements from YourBiology
30/04/2025
GLASGOW, United Kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- YourBiology Gut+ is the best probiotic for bloating, gas, and constipation—powered by Lactobacillus, Bifidobacterium, prebiotics, enzymes, and Vitamin D3 to [...]
Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
30/04/2025
Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”) [...]
Mise à disposition du rapport financier annuel 2024
30/04/2025
Communiqué de presse Mise à disposition du rapport financier annuel 2024 Dijon, France le 30 avril 2025 (17h45 CET) -- CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée en phase [...]
Mise à disposition du rapport financier annuel 2024
30/04/2025
Communiqué de presse Mise à disposition du rapport financier annuel 2024 Dijon, France le 30 avril 2025 (17h45 CET) -- CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée en phase [...]
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
30/04/2025
EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies to restore [...]
Guidance updated: Impact from and mitigation to navigate the global trade environment
30/04/2025
Following the recent announcements by the U.S. administration regarding tariffs, GN now takes further actions to counter the negative direct and indirect effects from the increased tariff levels. With the actions, GN is [...]
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
30/04/2025
KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) , a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it [...]
NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA
30/04/2025
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to alcohol during [...]
Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation
30/04/2025
Arialief offers innovative solutions for chronic pain and inflammation. Discover natural, non-addictive relief with our science-backed products. Improve your wellness journey today! FINDLAY, Ohio, April 30, 2025 (GLOBE [...]
X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate
30/04/2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded collaboration with Orion Pharma. The agreement [...]
BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
30/04/2025
MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton & Co. Healthcare Investor [...]
Corporate Update
30/04/2025
Boston, MA, April 30, 2025 (GLOBE NEWSWIRE) -- Vystar ® Corporation (OTCQB: VYST) Vystar received notice of final approval of its Form 15C-211 application. In addition, today the Company moved from the Pink Sheets to [...]
HLTH 2025 Launches Groundbreaking New Experiences in AI, Pharma, and Diagnostics – While Returning Classics Get a Fresh Twist
30/04/2025
LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the catalyst for global healthcare innovation, returns to Las Vegas on October 19–22, 2025, with a bold new agenda designed to redefine the future of healthcare. [...]
Best Male Enhancement Pills – Top Natural Male Enhancement Supplements & Gummies: Erectin Under Review By Leading Edge Health
30/04/2025
Looking to boost your performance and confidence naturally? Discover the top-rated male enhancement pills of 2025 — backed by science, trusted by men worldwide, and designed for real, lasting results! By Leading Edge [...]
Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness
30/04/2025
Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness MELBOURNE, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. ( OTC: FITY ), a leader [...]
Tencent Healthcare Unveils NGES R4.0: A Major Leap in Pharmaceutical Industry's Digital Transformation
30/04/2025
Shenzhen, China, April 30, 2025 (GLOBE NEWSWIRE) -- With the rapid popularization of AI technology, the global pharmaceutical industry is entering a crucial stage of digital transformation. Today, Tencent Healthcare has [...]
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
30/04/2025
SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment [...]

Pages